Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells

A Leone ¹, U Flatow , C R King

⁰Laboratory of Pathology National Cancer Institute, of Health Bethesda, Maryland 20892.

Cell +

|

April 5, 1991

View abstract on PubMed

Summary

The nm23 gene suppresses cancer progression. Introducing nm23-1 into melanoma cells reduced tumor formation and metastasis without affecting cell growth, highlighting nm23's role in controlling cancer spread.

Area Of Science

Oncology
Molecular Biology
Genetics

Background

Reduced nm23 gene expression is linked to increased tumor metastatic potential in human breast cancer and rodent models.
The nm23 gene's function in cancer progression remains incompletely understood.

Purpose Of The Study

To investigate the functional impact of nm23 expression on tumor metastasis and cancer processes.
To determine if nm23 expression affects tumor cell growth and response to cytokines.

Main Methods

Transfection of a murine nm23-1 expression construct into highly metastatic K-1735 TK murine melanoma cells.
Comparison of tumor formation, metastatic potential, and in vitro/in vivo growth characteristics between transfected and control cells.
Assessment of responses to transforming growth factor beta 1 in soft agar colonization assays.

Main Results

nm23-1 transfected clones showed reduced primary tumor formation and significantly decreased metastatic potential.
Tumor cell growth rates, both anchorage-dependent and independent, were not significantly altered by nm23-1 expression.
Altered responses to transforming growth factor beta 1 were observed in soft agar assays for nm23-1 expressing cells.

Conclusions

nm23 expression has a suppressive effect on key aspects of the cancer process, notably tumor metastasis.
nm23's role in metastasis is independent of its effect on intrinsic tumor cell proliferation.
These findings underscore the potential of nm23 as a therapeutic target for inhibiting cancer metastasis.

Related Concept Videos